Charles Schwab Investment Management Inc. Sells 12,061 Shares of Addus HomeCare Corporation $ADUS

Charles Schwab Investment Management Inc. decreased its position in shares of Addus HomeCare Corporation (NASDAQ:ADUS) by 5.4% in the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 212,115 shares of the company’s stock after selling 12,061 shares during the quarter. Charles Schwab Investment Management Inc. owned 1.15% of Addus HomeCare worth $20,976,000 at the end of the most recent reporting period.

Several other hedge funds have also recently bought and sold shares of the company. GAMMA Investing LLC lifted its holdings in shares of Addus HomeCare by 10,307.8% during the 1st quarter. GAMMA Investing LLC now owns 130,930 shares of the company’s stock worth $12,948,000 after acquiring an additional 129,672 shares during the period. Bank of America Corp DE increased its stake in Addus HomeCare by 273.6% in the fourth quarter. Bank of America Corp DE now owns 175,070 shares of the company’s stock valued at $21,945,000 after acquiring an additional 128,211 shares during the last quarter. Allianz Asset Management GmbH raised its position in Addus HomeCare by 1,229.4% during the first quarter. Allianz Asset Management GmbH now owns 100,898 shares of the company’s stock valued at $9,978,000 after purchasing an additional 93,308 shares in the last quarter. Principal Financial Group Inc. lifted its stake in Addus HomeCare by 18.3% during the first quarter. Principal Financial Group Inc. now owns 475,818 shares of the company’s stock worth $47,054,000 after purchasing an additional 73,720 shares during the last quarter. Finally, Raymond James Financial Inc. acquired a new stake in shares of Addus HomeCare in the 4th quarter valued at $6,637,000. 95.35% of the stock is owned by institutional investors.

Analyst Ratings Changes

A number of equities analysts have recently commented on ADUS shares. TD Cowen boosted their price target on Addus HomeCare from $135.00 to $139.00 and gave the stock a “buy” rating in a report on Wednesday, August 6th. JMP Securities reiterated a “market outperform” rating and issued a $150.00 target price on shares of Addus HomeCare in a research report on Wednesday, July 16th. Macquarie reissued an “outperform” rating and set a $133.00 target price on shares of Addus HomeCare in a research note on Tuesday, June 10th. Barclays increased their target price on shares of Addus HomeCare from $83.00 to $109.00 and gave the stock an “underweight” rating in a report on Tuesday. Finally, Wall Street Zen raised shares of Addus HomeCare from a “hold” rating to a “buy” rating in a report on Sunday, June 29th. Two investment analysts have rated the stock with a Strong Buy rating, six have assigned a Buy rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of “Buy” and a consensus price target of $138.63.

Addus HomeCare Stock Performance

NASDAQ ADUS opened at $114.18 on Friday. The company has a market capitalization of $2.10 billion, a price-to-earnings ratio of 25.21, a PEG ratio of 1.75 and a beta of 0.80. Addus HomeCare Corporation has a twelve month low of $88.96 and a twelve month high of $136.72. The stock has a fifty day simple moving average of $111.86 and a 200 day simple moving average of $107.13. The company has a quick ratio of 1.74, a current ratio of 1.74 and a debt-to-equity ratio of 0.17.

Addus HomeCare (NASDAQ:ADUS) last issued its quarterly earnings data on Monday, August 4th. The company reported $1.49 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.45 by $0.04. The company had revenue of $349.44 million during the quarter, compared to the consensus estimate of $345.71 million. Addus HomeCare had a return on equity of 9.39% and a net margin of 6.51%.The firm’s revenue was up 21.8% compared to the same quarter last year. During the same period last year, the company earned $1.35 earnings per share. Sell-side analysts expect that Addus HomeCare Corporation will post 4.59 EPS for the current year.

Insiders Place Their Bets

In related news, Director Veronica Hill-Milbourne sold 1,571 shares of the company’s stock in a transaction dated Tuesday, August 19th. The stock was sold at an average price of $114.93, for a total transaction of $180,555.03. Following the sale, the director owned 5,067 shares in the company, valued at $582,350.31. This represents a 23.67% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP Michael D. Wattenbarger sold 2,045 shares of the business’s stock in a transaction that occurred on Tuesday, May 27th. The shares were sold at an average price of $115.00, for a total value of $235,175.00. Following the completion of the transaction, the executive vice president directly owned 7,796 shares in the company, valued at approximately $896,540. This trade represents a 20.78% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 28,616 shares of company stock worth $3,289,480. Company insiders own 4.50% of the company’s stock.

Addus HomeCare Company Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.